H.Res. 866 · 116th Congress

Providing for consideration of the bill (H.R. 2339) to amend the Federal Food, Drug, and Cosmetic Act with respect to the sale and marketing of tobacco products, and for other purposes.

Stage
Passed chamber resolution
Introduced
2020-02-26
Latest action
2020-02-27 · Motion to reconsider laid on the table Agreed to without objection.

Action history

  1. 2020-02-27Motion to reconsider laid on the table Agreed to without objection.
  2. 2020-02-27On agreeing to the resolution Agreed to by the Yeas and Nays: 210 - 200 (Roll no. 75).
  3. 2020-02-27On ordering the previous question Agreed to by the Yeas and Nays: 224 - 189 (Roll no. 74).
  4. 2020-02-27Considered as unfinished business.
  5. 2020-02-27POSTPONED PROCEEDINGS - At the conclusion of debate on H. Res. 866, the Chair put the question on ordering the previous question and by voice vote, announced that the ayes had prevailed. Mr. Burgess demanded the yeas and nays and the Chair postponed further proceedings on the question on ordering the previous question until a time to be announced.
  6. 2020-02-27DEBATE - The House proceeded with one hour of debate on H. Res. 866.
  7. 2020-02-27Considered as privileged matter.
  8. 2020-02-26Rule provides for consideration of H.R. 2339 with 1 hour and 30 minutes of general debate. Motion to recommit with or without instructions allowed.
  9. 2020-02-26Introduced in House
  10. 2020-02-26The House Committee on Rules reported an original measure, H. Rept. 116-409, by Ms. Shalala.
  11. 2020-02-26Placed on the House Calendar, Calendar No. 74.